<?xml version="1.0" encoding="UTF-8"?>
<p id="Par9">Drug-related heart damage during COVID-19 treatment is a concern. In particular, the use of antiviral drugs should be monitored. In a study of 138 patients with COVID-19, 89.9% were given antiviral drugs
 <sup>
  <xref ref-type="bibr" rid="CR1">1</xref>
 </sup>. However, many antiviral drugs can cause cardiac insufficiency, arrhythmia or other cardiovascular disorders. Therefore, during treatment of COVID-19, especially with the use of antivirals, the risk of cardiac toxicity must be closely monitored
 <sup>
  <xref ref-type="bibr" rid="CR10">10</xref>
 </sup>.
</p>
